EBV, an inhibited receptor kinase, and lymphoma

Research output: Contribution to journalComment/debate

Abstract

In this issue of Blood, Huang et al investigate cellular gene expression profiles in Epstein-Barr virus (EBV)-immortalized B and normal B cells.1 They present evidence that a viral protein inhibits a cellular receptor tyrosine kinase (RTK) and that this inhibition is important in lymphomagenesis.

Original languageEnglish (US)
Pages (from-to)1542-1543
Number of pages2
JournalBlood
Volume128
Issue number12
DOIs
StatePublished - Sep 22 2016

Fingerprint

Complement 3d Receptors
Receptor Protein-Tyrosine Kinases
Viral Proteins
Human Herpesvirus 4
Viruses
Transcriptome
Gene expression
Lymphoma
Blood
Phosphotransferases

ASJC Scopus subject areas

  • Immunology
  • Biochemistry
  • Hematology
  • Cell Biology

Cite this

EBV, an inhibited receptor kinase, and lymphoma. / Ambinder, Richard F.

In: Blood, Vol. 128, No. 12, 22.09.2016, p. 1542-1543.

Research output: Contribution to journalComment/debate

Ambinder, Richard F. / EBV, an inhibited receptor kinase, and lymphoma. In: Blood. 2016 ; Vol. 128, No. 12. pp. 1542-1543.
@article{d44d2272e97c48dca9b7498976bc0998,
title = "EBV, an inhibited receptor kinase, and lymphoma",
abstract = "In this issue of Blood, Huang et al investigate cellular gene expression profiles in Epstein-Barr virus (EBV)-immortalized B and normal B cells.1 They present evidence that a viral protein inhibits a cellular receptor tyrosine kinase (RTK) and that this inhibition is important in lymphomagenesis.",
author = "Ambinder, {Richard F}",
year = "2016",
month = "9",
day = "22",
doi = "10.1182/blood-2016-08-724955",
language = "English (US)",
volume = "128",
pages = "1542--1543",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "12",

}

TY - JOUR

T1 - EBV, an inhibited receptor kinase, and lymphoma

AU - Ambinder, Richard F

PY - 2016/9/22

Y1 - 2016/9/22

N2 - In this issue of Blood, Huang et al investigate cellular gene expression profiles in Epstein-Barr virus (EBV)-immortalized B and normal B cells.1 They present evidence that a viral protein inhibits a cellular receptor tyrosine kinase (RTK) and that this inhibition is important in lymphomagenesis.

AB - In this issue of Blood, Huang et al investigate cellular gene expression profiles in Epstein-Barr virus (EBV)-immortalized B and normal B cells.1 They present evidence that a viral protein inhibits a cellular receptor tyrosine kinase (RTK) and that this inhibition is important in lymphomagenesis.

UR - http://www.scopus.com/inward/record.url?scp=84988693719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988693719&partnerID=8YFLogxK

U2 - 10.1182/blood-2016-08-724955

DO - 10.1182/blood-2016-08-724955

M3 - Comment/debate

C2 - 27658699

AN - SCOPUS:84988693719

VL - 128

SP - 1542

EP - 1543

JO - Blood

JF - Blood

SN - 0006-4971

IS - 12

ER -